JNHMF - Jack Nathan Medical Corp.

Other OTC - Other OTC Delayed price. Currency in USD
0.0692
0.0000 (0.00%)
At close: 10:19AM EDT
Stock chart is not supported by your current browser
Previous close0.0692
Open0.0692
BidN/A x N/A
AskN/A x N/A
Day's range0.0692 - 0.0692
52-week range0.0350 - 0.1560
Volume1
Avg. volume139
Market cap7.838M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-0.0600
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Simply Wall St.

    Jack Nathan Medical Full Year 2023 Earnings: CA$0.084 loss per share (vs CA$0.095 loss in FY 2022)

    Jack Nathan Medical ( CVE:JNH ) Full Year 2023 Results Key Financial Results Revenue: CA$15.5m (up 61% from FY 2022...

  • Business Wire

    Jack Nathan Health Announces Its Q4 and Year End Fiscal 2023 Financial Results

    TORONTO, June 02, 2023--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its audited consolidated annual financial results for the fourth quarter of fiscal 2023, and fiscal year ended January 31, 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

  • Business Wire

    Jack Nathan Health Announces Voting Results from Annual and Special Shareholders’ Meeting

    TORONTO, December 28, 2022--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") is pleased to announce that all of the matters presented for approval at its annual and special meeting of shareholders of the Company (the "AGM") held on Friday, December 23, 2022 were approved. The AGM was originally called for December 2, 2022, but was adjourned until December 23, 2022 (see the Company’s press release dated December 2, 2022).

  • Business Wire

    Jack Nathan Health Announces Q3 Fiscal 2023 Financial Results

    TORONTO, December 22, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated financial results for the third quarter of fiscal 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

  • Business Wire

    Jack Nathan Health Provides Corporate Update

    TORONTO, December 03, 2022--Jack Nathan Medical Corp. (TSXV: "JNH"; OTCQB: "JNHMF") (the "Company") reports that it has adjourned its annual and special meeting of shareholders of the Company (the "AGM") until 1:30 p.m. (Toronto time) on Friday, December 23, 2022. The adjourned meeting will be held in person on December 23 (rather than via zoom and teleconference) at the offices of Dickinson Wright LLP, 199 Bay Street, Suite 2200, Commerce Court West, Toronto Ontario, Canada. The rescheduling of

  • Business Wire

    Jack Nathan Health Announces Its Q2 Fiscal 2023 Financial Results

    TORONTO, September 29, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announced today its unaudited interim consolidated annual financial results for the second quarter of fiscal 2023. Jack Nathan Health’s financial statements are prepared in accordance with International Financial Reporting Standards ("IFRS").

  • Business Wire

    Jack Nathan Health to Secure a Revolving Credit Facility

    TORONTO, September 27, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") and Wal-Mart Canada Corp. ("Walmart Canada") announce today that they have entered into a loan agreement (the "Loan Agreement") in order to establish a new revolving credit facility in an amount not to exceed CAD$2,000,000 (the "Loan") in favour of the Company maturing on a date that is the earlier of (i) the date upon which demand is made by Walmart Canada pursuant to

  • Business Wire

    Jack Nathan Health to Appoint New Chief Financial Officer

    TORONTO, September 20, 2022--Jack Nathan Medical Corp. (TSXV: JNH, OTCQB: JNHMF) ("Jack Nathan Health", "JNH" or the "Company") announces that David Berman stepped down from his position as Chief Financial Officer of the Company effective as September 19, 2022. "On behalf of myself and the board of directors, we want to thank David for his contributions to Jack Nathan Health. He has been a key contributor to our success to date, and we wish him the best in his future endeavors," said Dr. Glenn C

  • Business Wire

    Jack Nathan Health Announces Its Q1 Fiscal 2023 Financial Results

    TORONTO, June 30, 2022--Jack Nathan Health Announces Q1-Fiscal 2023 Financial Results.